[PDF][PDF] B7-H3 Inhibitors in Oncology Clinical Trials: A Review

K Feustel, J Martin… - … of Immunotherapy and …, 2024 - meridian.allenpress.com
ABSTRACT B7-H3 is a transmembrane receptor highly prevalent on malignant cells and
plays an important role in adaptive immunity that is not fully elucidated. Targeted B7-H3 …